OXYCODONE MR APOTEX oxycodone hydrochloride 10mg modified release tablets blister pack

Country: Ástralía

Tungumál: enska

Heimild: Department of Health (Therapeutic Goods Administration)

Virkt innihaldsefni:

oxycodone hydrochloride, Quantity: 10 mg

Fáanlegur frá:

Arrotex Pharmaceuticals Pty Ltd

INN (Alþjóðlegt nafn):

oxycodone hydrochloride

Lyfjaform:

Tablet, modified release

Samsetning:

Excipient Ingredients: titanium dioxide; macrogol 8000; hypromellose; ethylcellulose; colloidal anhydrous silica; magnesium stearate; hyprolose; lactose

Stjórnsýsluleið:

Oral

Einingar í pakka:

28, 60, 20

Gerð lyfseðils:

(S8) Controlled Drug

Ábendingar:

OXYCODONE MR APOTEX modified release tablets are indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive; and ? requires daily, continuous, long-term treatment. OXYCODONE MR APOTEX is not indicated for the use in chronic non-cancer pain other than in exceptional circumstances. OXYCODONE MR APOTEX is not indicated as an as-needed (PRN) analgesia.

Vörulýsing:

Visual Identification: White, round, biconvex film-coated tablet, engraved 'APO' on one side, 'OCD' over '10' on the other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Leyfisstaða:

Licence status A

Leyfisdagur:

2014-11-21